Skip to content
10-Q

Quarterly Report

Semnur Pharmaceuticals, Inc. SMNR SMNRW

0001193125-25-277536

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 229.74M sh
Shares Diluted Q3 2025 · Sep 30, 2025 201.69M sh
Shares Diluted Q3 2025 · Sep 30, 2025 200.57M sh
Shares Diluted Q3 2025 · Sep 30, 2024 200M sh
Shares Diluted Q3 2025 · Sep 30, 2024 200M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.26M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$3.48M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $85K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $12K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$14.59M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$44.45M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$43.45M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$42.78M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$42.01M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$40.71M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 −$39.6M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$38.09M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.03M
Current Liabilities Q3 2025 · Dec 31, 2024 $35K
Total Liabilities Q3 2025 · Sep 30, 2025 $15.37M
Total Liabilities Q3 2025 · Dec 31, 2024 $49.47M
Current Assets Q3 2025 · Sep 30, 2025 $85K
Current Assets Q3 2025 · Dec 31, 2024 $6M
Total Assets Q3 2025 · Sep 30, 2025 $774K
Total Assets Q3 2025 · Dec 31, 2024 $6.68M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.76
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.77
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.02
Eps Basic Q3 2025 · Sep 30, 2025 −$0.76
Eps Basic Q3 2025 · Sep 30, 2025 −$0.77
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Eps Basic Q3 2025 · Sep 30, 2024 −$0.02
Sga Expense Q3 2025 · Sep 30, 2025 $151.45M
Sga Expense Q3 2025 · Sep 30, 2025 $152.43M
Sga Expense Q3 2025 · Sep 30, 2024 $1.07M
Sga Expense Q3 2025 · Sep 30, 2024 $2.44M
Rd Expense Q3 2025 · Sep 30, 2025 $1.14M
Rd Expense Q3 2025 · Sep 30, 2025 $1.83M
Rd Expense Q3 2025 · Sep 30, 2024 $233K
Rd Expense Q3 2025 · Sep 30, 2024 $1.47M
Net Income Q3 2025 · Sep 30, 2025 −$152.59M
Net Income Q3 2025 · Sep 30, 2025 −$154.26M
Net Income Q3 2025 · Jun 30, 2025 −$999K
Net Income Q3 2025 · Mar 31, 2025 −$665K
Net Income restated Q3 2025 · Sep 30, 2024 −$1.3M
Net Income restated Q3 2025 · Sep 30, 2024 −$3.91M
Net Income restated Q3 2025 · Jun 30, 2024 −$1.11M
Net Income restated Q3 2025 · Mar 31, 2024 −$1.51M
Operating Income Q3 2025 · Sep 30, 2025 −$152.59M
Operating Income Q3 2025 · Sep 30, 2025 −$154.26M
Operating Income restated Q3 2025 · Sep 30, 2024 −$1.3M
Operating Income restated Q3 2025 · Sep 30, 2024 −$3.91M